Elicio Therapeutics, Inc. · NASDAQ:ELTX

Elicio Therapeutics, Inc. shareholders

As of Sep 30, 2026, 77 institutions reported holding Elicio Therapeutics, Inc., 25.8% of its shares. Largest: Shah Capital Management, Knoll Capital Management, LLC and Vanguard. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Elicio Therapeutics, Inc.ChangeFiled
Shah Capital Management1.25M4.4%newOct 9, 2026
Knoll Capital Management, LLC1.21M4.3%no changeNov 16, 2026
Vanguard790K2.8%+36,322Nov 13, 2026
BlackRock740K2.6%−25,746Nov 13, 2026
Citadel543K1.9%newNov 16, 2026
AQR Capital Management LLC449K1.6%newNov 16, 2026
Geode Capital414K1.5%+103KNov 6, 2026
Morgan Stanley396K1.4%+370KNov 13, 2026
UBS236K0.83%+196KNov 10, 2026
State Street232K0.82%+52,822Nov 12, 2026

Elicio Therapeutics, Inc. insider trades